S173: RETROSPECTIVE STUDY OF LENALIDOMIDE DISCONTINUATION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME HARBORING DEL(5Q). A HARMONY ALLIANCE STUDY

• Elena Crisà,
• María Díez Campelo,
• Ulrich Germing,
• Elvira Mora Castera,
• Francisca Hernandez Mohedo,
• Kündgen Andrea,
• Ebeling Freja,
• Mikko Myllymäki,
• Martin Jädersten,
• Eva Hellström Lindberg,
• Detlef Haase,
• Isabella Capodanno,
• Antonella Poloni,
• Carlo Finelli,
• Monica Crugnola,
• Claudio Fozza,
• Anna Calvisi,
• Chiara Frairia,
• Giuseppe Pietrantuono,
• Marco Cerrano,
• Rosanna Ciancia,
• Daniela Barraco,
• Wolf-Karsten Hofmann,
• Axel Ruefer,
• Cécile Bally,
• Pierre Fenaux,
• Guillermo Sanz Santillana,
• Valeria Santini

Affiliations

Elena Crisà

1 Candiolo Cancer Institute, FPO-IRCCS, Oncology Division, Candiolo, Italy

María Díez Campelo

2 University Hospital of Salamanca, Hematology, Spain

Ulrich Germing

3 Klinik für Hämatologie, Onkologie and Klinische lmmunologie, Universitätsklinik Düsseldorf, Heinrich-Heine-Universität, Düsseldorf, Germany

Elvira Mora Castera

4 HU Politécnico La Fe, Valencia, Spain

Francisca Hernandez Mohedo

5 Hospital Universitario Virgen de las Nieves, Granada, Spain

Kündgen Andrea

3 Klinik für Hämatologie, Onkologie and Klinische lmmunologie, Universitätsklinik Düsseldorf, Heinrich-Heine-Universität, Düsseldorf, Germany

Ebeling Freja

6 Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland

Mikko Myllymäki

7 Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland

Martin Jädersten

9 Karolinska University Hospital, Department of Hematology, Stockholm, Sweden

Eva Hellström Lindberg

10 Karolinska University Hospital, Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Stockholm, Sweden

Detlef Haase

11 University Medical Center Göttingen, Clinics of Hematology and Medical Oncology, Göttingen, Germany

Isabella Capodanno

12 A.U.S.L.-IRCCS di Reggio Emilia, Reggio Emilia, Italy

Antonella Poloni

13 AOU Marche –Università Politecnica Marche, Ancona, Italy

Carlo Finelli

14 Istituto di Ematologia “Seràgnoli”, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

Monica Crugnola

15 University Hospital of Parma, Hematology Unit and BMT center, Parma, Italy

Claudio Fozza

16 Università di Sassari, Ematologia, Dipartimento di Medicina, Chirurgia e Farmacia, Sassari, Italy

Anna Calvisi

17 Ematologia CTMO, Osp San Francesco, Nuoro, Italy

Chiara Frairia

18 Hematology-University Hospital Città della Salute e della Scienza, Hematology, Torino, Italy

Giuseppe Pietrantuono

19 IRCCS CROB, Referral Cancer Center of Basilicata, Ematologia e Trapianto di cellule staminali, Rionero in vulture, Italy

Marco Cerrano

18 Hematology-University Hospital Città della Salute e della Scienza, Hematology, Torino, Italy

Rosanna Ciancia

21 IRCCS Centro di Riferimento Oncologico (CRO) di Aviano, Oncoematologia, trapianti emopoietici e terapie cellulari, Aviano, Italy

Daniela Barraco

22 ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Dipartimento di Ematologia, Varese, Italy

Wolf-Karsten Hofmann

23 University of Mannheim, Hematology and Oncology, Mannheim, Germany

Axel Ruefer

24 Abteilung Hämatologie und Hämatologisches Zentrallabor, Luzern, Switzerland

Cécile Bally

25 Hématologie clinique, hôpital Necker. Assistance publique hôpitaux de Paris (APHP), Paris, France

Pierre Fenaux

26 Service d’hématologie seniors Hôpital St Louis/université de Paris, Département (DMU) d’hématologie et immunologie, APHP Nord, Paris, France

Guillermo Sanz Santillana

27 Hospital Universitario y Politécnico La Fe, Instituto de Investigación Sanitaria La Fe, Valencia, Spain and CIBERONC, ISCIII, Madrid, Spain

Valeria Santini

28 AOU Careggi University of Florence, Dipartimento Medicina Sperimentale e Clinica SOD Ematologia, Firenze, Italy